Glaukos
Abbas Sedigh is a Senior Scientist at Glaukos Corporation, specializing in drug delivery innovation and early-stage ocular formulation development. Prior to this role, Abbas worked at AbbVie as an Associate Scientist focusing on novel sustained release technologies. With a background in cellular and molecular biology, Abbas has also conducted research at North Dakota State University, where Abbas worked on drug delivery platforms and drug screening. In addition, Abbas has experience lecturing on biology and cellular molecular biology at Payame Noor University. Abbas holds a Master of Science degree in Cellular and Molecular Biology from North Dakota State University and a Bachelor's degree in Biology from the University of Zanjan.
This person is not in any teams
Glaukos
3 followers
At Glaukos, their focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.